Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05596734
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza

Who this might be right for
Influenza, HumanCOVID-19
BioNTech SE 1,019
Large-scale testing (Phase 3)Study completedNCT00700193
What this trial is testing

The Safety, Tolerability & Immunogenicity of CSL Limited's Influenza Virus Vaccine In a Paediatric Population

Who this might be right for
Influenza
Seqirus 298
Testing effectiveness (Phase 2)Study completedNCT01080716
What this trial is testing

Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate

Who this might be right for
DysenteryShigellaDiarrhea
U.S. Army Medical Research and Development Command 30
Early research (Phase 1)Study completedNCT00375206
What this trial is testing

A Safety and Immunology Study of a DNA Trivalent Influenza Vaccine

Who this might be right for
Influenza
PowderMed 189
Large-scale testing (Phase 3)Study completedNCT00241644
What this trial is testing

Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African Infants

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 2,089
Post-approval studies (Phase 4)Study completedNCT06994052
What this trial is testing

Study on Booster Immunization With Varicella Vaccine at Different Intervals

Who this might be right for
VZVVaricella Immunisation
Sinovac (Dalian) Vaccine Technology Co., Ltd. 412
Large-scale testing (Phase 3)Study completedNCT01967784
What this trial is testing

Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in Taiwan

Who this might be right for
Influenza
Sanofi Pasteur, a Sanofi Company 100
Early research (Phase 1)Study completedNCT03382964
What this trial is testing

Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers

Who this might be right for
Chikungunya
Valneva Austria GmbH 120
Large-scale testing (Phase 3)Study completedNCT00366899
What this trial is testing

Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Infants

Who this might be right for
Vaccines, Pneumococcal
Wyeth is now a wholly owned subsidiary of Pfizer 605
Testing effectiveness (Phase 2)Study completedNCT04533399
What this trial is testing

A Study Looking at the Effectiveness and Safety of a COVID-19 Vaccine in South African Adults

Who this might be right for
SARS-CoV-2 InfectionCOVID-19
Novavax 4,422
Testing effectiveness (Phase 2)Study completedNCT00995033
What this trial is testing

Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)

Who this might be right for
Smoking BehaviorSmoking Lapse BehaviorSmoking Relapse Behavior
Maastricht University Medical Center 558
Early research (Phase 1)Not Yet RecruitingNCT07406347
What this trial is testing

A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age

Who this might be right for
Pneumonia, Bacterial
GlaxoSmithKline 60
Early research (Phase 1)Study completedNCT00124007
What this trial is testing

Safety of and Immune Response to an Adenoviral HIV Vaccine (VRC-HIVADV014-00-VP) With or Without a Plasmid HIV Vaccine (VRC-HIVDNA016-00-VP) in HIV Uninfected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 114
Post-approval studies (Phase 4)Looking for participantsNCT07252804
What this trial is testing

Immunogenicity and Safety of MenB Vaccine in Pediatric Patients With Autoimmune Rheumatic Diseases

Who this might be right for
Autoimmune Rheumatologic Disease
University of Sao Paulo General Hospital 263
Testing effectiveness (Phase 2)Study completedNCT01377571
What this trial is testing

A Dose-escalating Study to Evaluate the Immunogenicity and Safety of Rotavin-M1 Vaccine in Healthy Infants

Who this might be right for
DiarrheaFeverNausea+2 more
National Institute of Hygiene and Epidemiology, Vietnam 200
Early research (Phase 1)Study completedNCT02017899
What this trial is testing

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

Who this might be right for
Shigellosis
GSK Vaccines Institute For Global Health S.r.l. 50
Not applicableStudy completedNCT05285384
What this trial is testing

Immunogenicity and Safety of a Booster Dose of the SpikoGen Vaccine in Kidney Transplant Recipients After Two Doses of Sinopharm Vaccine

Who this might be right for
COVID-19
Cinnagen 43
Testing effectiveness (Phase 2)Study completedNCT01035749
What this trial is testing

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

Who this might be right for
Influenza
GlaxoSmithKline 310
Testing effectiveness (Phase 2)Active Not RecruitingNCT07280858
What this trial is testing

A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults.

Who this might be right for
Healthy ParticipantsSarbecovirus
SK Bioscience Co., Ltd. 368
Large-scale testing (Phase 3)Study completedNCT01991899
What this trial is testing

Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months.

Who this might be right for
MeaslesMumpsRubella+1 more
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,560
Next Page